Miami Cancer Institute Multispecialty Grand Rounds: Oral Precancers - New Management Options

June 12, 2023

Accurate assessment of the carcinogenic potential of oral mucosal diseases can significantly reduce the prevalence of oral cancer. During the grand rounds, participants will learn about current management strategies for precancerous oral lesions and discuss new treatment options for oral precancers.  

This course will be live at MCI 3N110  and Virtual

Target Audience

Oncologists, Radiation Oncologists, Hematology Oncologists, Radiation Therapists, Endocrinologists, Pulmonologists, Otolaryngologists,  General Surgeons, General Practitioners, Obstetricians and Gynecologists, Nurses, Social Workers, Patient Navigators and all other interested healthcare professionals.

Learning Objectives

  • Identify the clinical presentation of oral precancers.
  • Implement current management strategies for oral precancerous lesions. 
  • Discuss new treatment options for oral precancers. 
     
Course Summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 General certificate of attendance
  • 1.00 Nurse Practitioners
  • 1.00 Florida Board of Nursing
  • 1.00 Florida Board of Respiratory Therapy
Course opens: 
05/07/2023
Course expires: 
09/30/2023
Event starts: 
06/12/2023 - 7:30am EDT
Event ends: 
06/12/2023 - 8:30am EDT
Add to calendar: 
Rating: 
0
Live and Zoom
United States

Alessandro Villa, DDS, Ph.D., MPH
Chief of Oral Medicine
Oral Oncology and Dentistry
Miami Cancer Institute
Miami, Florida

Alessandro Villa, DDS., faculty for this educational activity, is a consultant for Merck, Lipella Pharmaceuticals and AFYX Therapeutics.  He receives royalties/patent benefits from Up-To-Date.  He has indicated that the presentation or discussions will not include off-label or unapproved product usage.

Guilherme Rabinowits, M.D., conference series director, has indicated that he is an advisor with Sanofi-Genzyme, Regeneron, Castle and Boston Gene.  All of the relevant financial relationships listed for this individual have been mitigated.

Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships with ineligible companies* to disclose.  

*Ineligible companies - Companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Disclosure Policy and Disclaimer

Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.

Baptist Health South Florida designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity has been approved for 1 credit hour, CE Broker Course #20-680158, by the Florida Boards of Medicine, Osteopathic Medicine and by the Florida Council of Physician Assistants.

This activity has also been approved for 1 credit hour for Nurse Practitioners, Nurses and Respiratory Therapists. Baptist Health South Florida CE Broker Provider #50-182.

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 General certificate of attendance
  • 1.00 Nurse Practitioners
  • 1.00 Florida Board of Nursing
  • 1.00 Florida Board of Respiratory Therapy
Please login or register for a Baptist Health CME account to take this course.

This course is available Live at MCI – Rad-Onc 3N110 or Via Zoom Webinar. Please choose one of the options below.

Register for the live conference

Register for the virtual conference